ROBIN COOPER: Open Payments
NPI 1558746701 · GALESBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 14 payments from 7 companies in 2025. Trend: 2023 $174 · 2024 $458 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $359 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $230 |
| GlaxoSmithKline, LLC. | 1 | $130 |
| SCPHARMACEUTICALS INC. | 1 | $112 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $85 |
| Novartis Pharmaceuticals Corporation | 1 | $73 |
| Abbott Laboratories | 1 | $23 |
Products named: JARDIANCE, NUCALA, AIRSUPRA, FARXIGA, BREZTRI, FUROSCIX, LifeVest, LEQVIO.
Industry payments across IL — which companies pay providers there.
